中国P站

Surface Plasmon Resonance; SPR Biosensors; Clinical Diagnostics; Pharmaceutical Analysis; Food Safety; Protein-Ligand Interactions; Microfluidics; LSPR; Fiber Optic Sensors; SARS-CoV-2 Detection

Introduction

Surface Plasmon Resonance (SPR) biosensors represent a dynamic and rapidly evolving field, offering label-free, real-time detection capabilities essential for a myriad of analytical applications. The journey of SPR technology involves continuous innovation in fabrication techniques, aiming to push the boundaries of sensitivity and specificity, making these sensors increasingly effective for diverse analytical needs [1].

In clinical settings, SPR biosensors are making substantial strides, particularly for point-of-care diagnostics and the simultaneous handling of multiple detection targets [2].

This shift towards more accessible and comprehensive diagnostic tools is a significant development for patient care, streamlining processes and providing faster results. A notable application within this domain involved the critical detection of SARS-CoV-2 during the recent pandemic [3].

Different approaches demonstrated the speed and sensitivity SPR offers for viral detection, proving crucial for rapid diagnostics and understanding viral interactions in a public health crisis. Further expanding their reach, fiber optic SPR biosensors are at the forefront of innovation, integrating SPR with optical fibers to improve performance and create new application avenues [4].

This integration makes sensors more compact, versatile, and capable of in-situ measurements, representing a considerable leap forward in sensor design and utility. The pharmaceutical industry also heavily benefits from these advancements, where SPR biosensors are becoming indispensable for pharmaceutical analysis, from drug discovery to quality control [5].

These sensors provide precise, real-time insights into molecular interactions, which is essential for developing new drugs and ensuring their efficacy and safety throughout their lifecycle. Localized Surface Plasmon Resonance (LSPR) biosensors present another exciting development, specifically for their potential in advanced biomedical applications [6].

LSPR offers enhanced sensitivity and spatial resolution, making it particularly powerful for detecting specific biomarkers and for cell-based assays. This capability is a game-changer for personalized medicine, allowing for more precise and tailored diagnostic and therapeutic approaches. Beyond the medical realm, SPR biosensors play a crucial role in ensuring food safety [7].

They are employed to detect contaminants, allergens, and pathogens, providing rapid and reliable results that are absolutely vital for protecting public health and maintaining food quality standards globally. The fundamental principles of SPR-based immunoassays highlight their broad applicability [8].

These assays offer label-free and real-time detection of immune complexes, serving as a powerful tool for diagnostics and understanding complex immune responses. This deep dive into immunology truly pushes the field forward by enabling dynamic observation of interactions. Similarly, SPR biosensors are invaluable for studying protein-ligand interactions [9].

They provide real-time, label-free kinetic and affinity data, which is essential for drug discovery efforts and for gaining a deeper understanding of fundamental biological processes, solidifying their status as an indispensable tool in biochemistry. Looking ahead, the powerful combination of SPR with microfluidics is creating highly efficient biosensing platforms [10].

What this really means is achieving miniaturization, automation, and reduced sample consumption. This integration makes complex analyses much more accessible and high-throughput for a wide range of applications, from clinical diagnostics to environmental monitoring, promising a future where advanced analytical capabilities are more widely available and easier to implement. The continuous evolution of SPR technology, therefore, underscores its pivotal role in addressing contemporary challenges across science, medicine, and industry.

Description

Surface Plasmon Resonance (SPR) biosensors have evolved significantly, becoming a cornerstone technology for label-free, real-time analytical measurements across various disciplines. The core advancements center around innovative fabrication techniques, which are continuously refined to push the boundaries of sensitivity and specificity. These improvements ensure the sensors are more effective and adaptable for a wide range of analytical needs, from fundamental research to applied diagnostics [1]. This constant drive for better performance underscores the dynamic nature of SPR research.

In the medical sector, SPR biosensors have carved out a critical niche. They are increasingly employed in clinical applications, particularly for point-of-care diagnostics, which allows for immediate testing and results outside traditional laboratory settings [2]. Furthermore, their capability to handle multiple detection targets simultaneously enhances diagnostic efficiency and comprehensiveness, significantly improving patient care outcomes. A salient example of their utility in public health emerged during the SARS-CoV-2 pandemic [3]. SPR biosensors were crucial for developing rapid and sensitive methods for viral detection, providing insights into viral interactions and supporting critical diagnostic needs when speed and accuracy were paramount.

The versatility of SPR technology is further exemplified by specialized adaptations and integrations. Fiber optic SPR biosensors represent a cutting-edge development, where the integration of SPR with optical fibers leads to improved performance and opens up new avenues for application [4]. This innovation allows for more compact, versatile, and in-situ measurement capabilities, marking a substantial step forward in sensor design. Another powerful variant, Localized Surface Plasmon Resonance (LSPR) biosensors, shows exciting potential in advanced biomedical applications [6]. LSPR offers enhanced sensitivity and spatial resolution, which is particularly advantageous for detecting specific biomarkers and for sophisticated cell-based assays, thereby paving the way for more personalized and targeted medical interventions.

Beyond clinical diagnostics, SPR biosensors are proving indispensable in pharmaceutical analysis. From the initial stages of drug discovery to rigorous quality control processes, these sensors offer precise, real-time insights into molecular interactions [5]. This capability is absolutely essential for understanding drug mechanisms, optimizing drug candidates, and ensuring the efficacy and safety of pharmaceutical products. Simultaneously, SPR biosensors play a vital role in ensuring food safety [7]. They are effectively used for the rapid and reliable detection of various contaminants, allergens, and pathogens in food products, which is crucial for protecting public health and maintaining stringent food quality standards worldwide.

The foundational mechanisms underpinning SPR technology also facilitate advanced analytical methods. SPR-based immunoassays, for instance, capitalize on the principle of label-free, real-time detection of immune complexes [8]. This makes them a powerful tool for both diagnostic applications and for advancing our understanding of complex immune responses. Similarly, in biochemistry, SPR biosensors are invaluable for meticulously studying protein-ligand interactions [9]. They deliver real-time, label-free kinetic and affinity data, which is fundamental for accelerating drug discovery efforts and elucidating intricate biological processes at a molecular level.

Looking to the future, the powerful synergy between SPR and microfluidics is creating highly efficient biosensing platforms [10]. What this really means is achieving significant miniaturization, automation of analytical processes, and a reduction in sample consumption. This integration simplifies complex analyses, making them more accessible and capable of high-throughput operation for a diverse array of applications, ranging from environmental monitoring to advanced clinical diagnostics. The continuous innovation across these areas underscores the enduring impact and adaptability of SPR biosensor technology in addressing contemporary scientific and societal challenges.

Conclusion

Surface Plasmon Resonance (SPR) biosensors are undergoing significant advancements, marking their importance across various scientific and clinical domains. Innovations in fabrication techniques are continuously enhancing their sensitivity and specificity, pushing the boundaries for effective analytical needs. The technology's utility extends broadly, from critical clinical applications like point-of-care diagnostics and multiplexed detection to specific viral detection efforts, notably during the SARS-CoV-2 pandemic. Beyond healthcare, SPR biosensors are proving indispensable in pharmaceutical analysis, aiding drug discovery and quality control by providing real-time insights into molecular interactions. Advancements also include integrating SPR with optical fibers, making sensors more compact and versatile for in-situ measurements. Localized SPR (LSPR) offers enhanced sensitivity and spatial resolution, opening new possibilities for biomedical applications and biomarker detection. Furthermore, SPR biosensors play a vital role in food safety monitoring, enabling rapid and reliable detection of contaminants, allergens, and pathogens. The underlying principles of SPR-based immunoassays facilitate label-free, real-time detection of immune complexes, while their application in studying protein-ligand interactions provides essential kinetic and affinity data for biochemistry. The integration of SPR with microfluidics platforms promises miniaturization, automation, and reduced sample consumption, making complex analyses more accessible and high-throughput. Overall, SPR technology continues to evolve, addressing diverse analytical challenges with increasing sophistication.

References

1. Xia L, Ziqi S, Yue P (2023) .Biosens Bioelectron 239:115024.

   , ,

2. Ziyun L, Hao M, Dongdong W (2022) .Biosens Bioelectron 214:114387.

   , ,

3. Yu-Ting C, Hao-Ting W, Wei-Ting C (2021) .Biosens Bioelectron 190:113067.

   , ,

4. Xiaoyu S, Jianlei W, Hao W (2024) .J Anal Sci Technol 15:7.

   , ,

5. Zixuan L, Linlin D, Yanxia F (2023) .TrAC Trends Anal Chem 171:117070.

   , ,

6. Shuo W, Mengmeng Z, Lingling L (2022) .Biosens Bioelectron 213:114316.

   , ,

7. Xiaona L, Yanli W, Wei W (2021) .Food Control 129:108259.

   , ,

8. Bin L, Hongye L, Ruihong L (2020) .Biosens Bioelectron 168:112444.

   , ,

9. Qianqian L, Ruofei L, Xianglong L (2023) .Anal Chem Front 7:6972-6987.

   , ,

10. Junmei H, Xiangyu M, Huiming Z (2024) .Biosens Bioelectron 248:115865.

    , ,